We are a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Established in 1973, we produce high-quality branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which we market in India and over 50 countries internationally. With a comprehensive portfolio of over 700 brands covering all the major therapeutic segments and a robust pan-India sales and distribution network, we have been ranked amongst the top ten pharmaceutical companies in India in terms of domestic sales for the past 13 years. We have also been ranked the No.1 Anti-infective company in India for the past 10 years and feature amongst the leading pharmaceutical companies in the therapeutic segments of Gastro-intestinal, Pain management and Vitamins / Minerals / Nutrients. We are currently ranked the fifth largest pharmaceutical company in India in terms of domestic sales for the fiscal year 2016 with our iconic brands like Clavam, Pan, Pan-D, Taxim and Taxim-O featuring amongst the top 50 pharmaceutical brands in India.
Apart from having a strong foothold in the domestic market, we also have presence in more than 50 international markets, with the United States being the key focus International market. Our International business contributed about 27% to our overall revenues in fiscal year 2016 and is one of the important growth drivers for the company.
We have an extensive manufacturing footprint with a total of 16 manufacturing facilities including 14 in India and 2 the United States. Six of our facilities are USFDA approved. We also have strong research and development capabilities with over 500 scientists working across our four globally located R&D centres.
On December 23, 2015, we successfully completed our Initial Public Offering (IPO) with our equity shares being listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.+ Read More